跳至主要内容
临床试验/CTRI/2022/06/043138
CTRI/2022/06/043138招募中未知

Single Oral Dose of Azithromycin 2gm to Prevent Maternal Peri-partum Infection and Newborn Sepsis in Laboring women (A-PLUS Trial): Repurposing Azithromycin as a Neuro-protector: A Neurodevelopmental Follow-up Secondary Study

Thrasher Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Survivor of birth asphyxia (more than or equal to 34 weeks of gestational age) with no, mild, moderate or severe hypoxic ischemic encephalopathy (categorized by neurological examination using the Modified Sarnat Score) born to a mother who received either a single oral dose of 2 grams of azithromycin or placebo during labor as part of the A-PLUS RCT and willing to participate in neurodevelopmental assessment at 24(plus or minus 1) months of age.
  • Birth asphyxia is defined as any of the following- received positive pressure ventilation at birth and or a 5-min Apgar score less than 7

排除标准

  • Prenatally or postnatally diagnosed or suspected genetic disorders, neurologic diseases, and other diseases that affect neurodevelopment

研究者

发起方
Thrasher Research Foundation

相似试验